Management of Metastatic Renal Clear Cell Cancer: ASCO Guideline Rapid Recommendation Update
2023; Lippincott Williams & Wilkins; Volume: 41; Issue: 33 Linguagem: Inglês
10.1200/jco.23.01977
ISSN1527-7755
AutoresEric A. Singer, R. Bryan Rumble, W. Kimryn Rathmell, Peter J. Van Veldhuizen, W. Kimryn Rathmell, Peter J. Van Veldhuizen, R. Bryan Rumble, Hikmat Al‐Ahmadie, Hamid Emamekhoo, Ralph J. Hauke, Alexander V. Louie, Matthew I. Milowsky, Ana M. Molina, Tracy L. Rose, Shankar Siva, Nicholas G. Zaorsky, Tian Zhang, Rubina Qamar, Terry Kungel, Bryan Lewis, Eric A. Singer,
Tópico(s)Renal and related cancers
ResumoASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in theASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. See the Appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).
Referência(s)